Back to search results

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Lymphoblastic Leukemia, in Relapse · Acute Lymphoblastic Leukemia, Refractory · Pediatric ALL

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • St. Jude Children's Research Hospital, Memphis, Tennessee, United States

    Contact: Study coordinator (Aimee C. Talleur, MD) · referralinfo@stjude.org · 866-278-5833
    Contact: Principal Investigator (Aimee C. Talleur, MD)
    Contact: Principal Investigator (Stephen Gottschalk, MD)
Study leads

  • Aimee C. Talleur, MD

    Principal Investigator

    St. Jude Children's Research Hospital

  • Stephen Gottschalk, MD

    Principal Investigator

    St. Jude Children's Research Hospital

View source on ClinicalTrials.gov(opens in a new tab)